Julia Varghese

Julia Varghese

Auto-generated profile, based on publicly available information

Julia Varghese

University of British Columbia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Clinica Chimica Acta
Verified
Journal Article
Closed access
JVJulia L. Varghese
Julia L. Varghese
AFAngela Fung
Angela Fung
AMAndre Mattman
Andre Mattman
TQTien T.T. Quach
Tien T.T. Quach
DGDeonne Thaddeus V. Gauiran
Deonne Thaddeus V. Gauiran
LCLuke Y.C. Chen
Luke Y.C. Chen

2 April 2026 in American Journal of Hematology
Verified
Journal Article
Open access
PDF file
ELEmily Leung
Emily Leung
NFNicholas R. Fragola
Nicholas R. Fragola
ESElliott W. Sharp
Elliott W. Sharp
RHRebecca Harrison
Rebecca Harrison
EPErica Peterson
Erica Peterson
LCLuke Y. C. Chen
Luke Y. C. Chen
A combined clinical and computational pharmacophenomic study from the Coastal Rare Inflammatory Diseases Program and Every Cure.

8 September 2025 in Journal of Human Immunity
Verified
Journal Article
Open access
RSRichard Schwarzkopf
Richard Schwarzkopf
ACAndrew A.Y. Chen
Andrew A.Y. Chen
SQStephanie Quon
Stephanie Quon
JVJulia Varghese
Julia Varghese
JRJanet Helen Roberts
Janet Helen Roberts
LCLuke Y.C. Chen
Luke Y.C. Chen
Two adult patients with severe immune neutropenia refractory to standard therapies achieved durable remission following treatment with the JAK inhibitor ruxolitinib. This report highlights the potential of JAK–STAT pathway inhibition for managing G-CSF and steroid-refractory immune-mediated neutropenia.

5 November 2025 in Clinical Lymphoma Myeloma and Leukemia
Verified
Journal Article
Closed access
JVJulia Varghese
Julia Varghese
CVChristopher P Venner
Christopher P Venner
MLMartha Louzada
Martha Louzada
DRDonna Reece
Donna Reece
DWDarrell White
Darrell White
RLRichard LeBlanc
Richard LeBlanc

3 August 2026 in Expert Review of Clinical Immunology
Verified
Journal Article
Closed access
RMRebecca MacLeod
Rebecca MacLeod
MTMark Trinder
Mark Trinder
LWLiliana Wolak
Liliana Wolak
SQStephanie Quon
Stephanie Quon
MBMarley Blommers
Marley Blommers
LCLuke Y.C. Chen
Luke Y.C. Chen
1. Castleman disease (CD) is a rare disease characterized by lymphadenopathy and a wide range of clinical manifestations ranging from focal lymphadenopathy to diffuse lymphoproliferation, systemic ...

28 May 2026 in Leukemia Research
Verified
Journal Article
Closed access
HLHong Li
Hong Li
TWTimothy Wong
Timothy Wong
ARArefeh Rouhi
Arefeh Rouhi
YAYasser Abou-Mourad
Yasser Abou-Mourad
HCHannah Cherniawsky
Hannah Cherniawsky
FKFlorian Kuchenbauer
Florian Kuchenbauer